CA-NETAPP
14.5.2024 14:02:00 CEST | Business Wire | Press release
NetApp® (NASDAQ: NTAP), the intelligent data infrastructure company, today announced NetApp AIPod with Lenovo ThinkSystem servers for NVIDIA OVX, a converged infrastructure optimized for the generative AI era. NetApp and Lenovo have had a strong partnership for over five years and are now taking the partnership to the next level with the introduction of this simple, cost-effective, and powerful solution for enterprise AI. The new converged infrastructure solution will support NVIDIA NIM inference microservices, the NVIDIA AI Enterprise software platform for generative AI development and deployment, and retrieval-augmented generation (RAG) to enable customers to leverage their private, proprietary data for AI without large-scale model training.
Generative AI has created extensive opportunities for organizations, though many may feel as if AI is out of reach due to the cost, integration complexity, and time to deployment. Meanwhile, pre-built large language models (LLMs) often do not have training on the most up-to-date or relevant data organizations need to generate valuable insights or effectively automate routine tasks.
NetApp has led in unstructured data storage for over three decades, and much of the world’s enterprise unstructured data is stored in NetApp storage. Unlocking the full value of this data requires going far beyond foundational model training. By enabling inferencing and RAG, the NetApp AIPod with Lenovo’s leading server reliability, quality, and performance makes it seamless, simple, and fast to combine the power of LLMs with precise, up-to-date, and pertinent information on NetApp storage.
"The NetApp AIPod with Lenovo ThinkSystem servers for NVIDIA OVX transforms enterprise AI by delivering a pre-integrated, high-performance solution that accelerates the deployment and scaling of generative AI workloads," said Sandeep Singh, Senior Vice President & General Manager, Enterprise Storage at NetApp. "Through our collaboration with NVIDIA and Lenovo, NetApp is empowering organizations to harness the capabilities of AI more efficiently, ensuring that they can focus on creating value and gaining insights from their data without the complexity of building and managing AI infrastructure from scratch."
NetApp AIPod combines NetApp's robust storage systems with hybrid cloud data management, including Lenovo's high-performance ThinkSystem SR675 V3 servers, the leading platforms supporting NVIDIA-certified OVX architecture with NVIDIA L40S GPUs, as well as NVIDIA Spectrum-X Networking, providing a complete and seamless infrastructure solution to streamline AI adoption. Using this solution, customers will be able to conduct AI RAG and inferencing operations for use cases like chatbots, knowledge management, and object recognition. NetApp, in collaboration with Lenovo and NVIDIA, simplifies AI deployment by seamlessly integrating into ecosystems, simplifying operations, accelerating implementation, and safeguarding AI infrastructure, enabling organizations to unlock AI's full potential.
“Lenovo is expanding our partnership with NetApp and NVIDIA to bring the power of AI to every business as part of our continued commitment to enabling and simplifying hybrid AI for our joint customers,” said Kirk Skaugen, President of Lenovo Infrastructure Solutions Group. “As customers deploy AI, they demand business critical availability, ease of management, and infrastructure efficiency. The NetApp AIPod with Lenovo ThinkSystem servers for NVIDIA OVX delivers optimized and validated solutions to make generative AI more accessible for businesses of every size.”
“Making AI accessible and scalable for every industry is more important than ever,” said Bob Pette, Vice President of Enterprise Platforms at NVIDIA. “The NetApp AIPod with Lenovo for NVIDIA OVX offers an AI-ready platform that’s powerful and easy to use, enabling businesses to drive innovation.”
NetApp AIPod with Lenovo for NVIDIA OVX will be available by summer 2024.
Additional Resources
- NetApp AIPodTM with Lenovo for NVIDIA OVX: The Power of Retrieval-Augmented Generation for Every Enterprise
- NetApp Unveils Unified Data Storage Built for the AI Era
- AIPod: Delivering the Promise
About NetApp
NetApp is the intelligent data infrastructure company, combining unified data storage, integrated data services, and CloudOps solutions to turn a world of disruption into opportunity for every customer. NetApp creates silo-free infrastructure, harnessing observability, and AI to enable the industry’s best data management. As the only enterprise-grade storage service natively embedded in the world’s biggest clouds, our data storage delivers seamless flexibility. In addition, our data services create a data advantage through superior cyber resilience, governance, and application agility. Our CloudOps solutions provide continuous optimization of performance and efficiency through observability and AI. No matter the data type, workload, or environment, with NetApp you can transform your data infrastructure to realize your business possibilities. Learn more at www.netapp.com or follow us on X, LinkedIn, Facebook, and Instagram.
NETAPP, the NETAPP logo, and the marks listed at www.netapp.com/TM are trademarks of NetApp, Inc. Other company and product names may be trademarks of their respective owners.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240514466001/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
KATE Launches "KABUKE: Break Convention" Kabuki-Inspired International Campaign17.7.2026 09:00:00 CEST | Press release
Where “NO MORE RULES.” intersects with the Kabuku spirit. Inspired by Japanese aesthetics, KATE shares the value of shadow enhancing makeup and self‑expression with the world. Global cosmetics brand KATE launched “KABUKE: Break Convention,” a new international campaign drawing on elements of Kabuki, the traditional Japanese performing art. The campaign debuted on Wednesday, July 8, 2026. In this campaign, KATE’s shadow enhancing makeup—rooted in Japanese aesthetics—was paired with the Kabuki spirit inherited from traditional Kabuki theater to communicate the value of individuality and self‑expression through makeup on a global scale. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260708829427/en/ KATE international campaign “KABUKE: Break Convention” key visual. Dedicated website: https://www.kate-global.net/my/special/kate_kabuki/ Since its founding, KATE has championed the slogan “NO MORE RULES.,” offering makeup that defi
Meiji Seika Pharma: Results from the Global Phase III Trial (Integral-2) of Nacubactam, a Novel β-Lactamase Inhibitor, Highlighted in The Lancet Microbe’s Coverage of ESCMID Global Congress 202617.7.2026 03:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, President and Representative Director: Toshiaki Nagasato) today announced that results from the global Phase III trial (Integral-2) of nacubactam (Development Code: OP0595), a novel β-lactamase inhibitor, were highlighted in The Lancet Microbe’s coverage of ESCMID Global Congress 2026 (held in Munich, Germany). As highlighted in The Lancet Microbe’s coverage, the key findings presented by Meiji Seika Pharma at ESCMID Global Congress 2026 are as follows: The Integral-2 study (jRCT2031230076) is a global Phase III clinical trial that enrolled patients with complicated urinary tract infections, acute uncomplicated pyelonephritis, hospital-acquired bacterial pneumonia, ventilator-associated bacterial pneumonia, or complicated intra-abdominal infections caused by carbapenem-resistant Gram-negative bacteria (excluding Acinetobacter species). The study has achieved the prespecified study objectives. For the primary endpoint of overall treatme
Yoshihiro Shimamura Joins the Marché du Film’s “Investors Circle 2026” as an Invited Investor, Backing a New Feature Film17.7.2026 03:00:00 CEST | Press release
Shimamura Yoshihiro Film Production Co., Ltd. (Head office: Osaka, Japan; Representative Director: Yoshihiro Shimamura), a company active in film production and investment, today announced that Representative Director Yoshihiro Shimamura has decided to invest in an international feature film after being invited to the “Investors Circle 2026” — a distinction that reflects his standing as one of the field’s most highly regarded producers and investors. Hosted by the Marché du Film, the business arm of the Festival de Cannes and one of the world’s largest film markets, the Investors Circle is an invitation-only summit that connects a select group of private investors with high-end feature films during early-stage financing. Held in Cannes, France, May 16-17, 2026, it brings internationally acclaimed directors and producers together with investors around a curated slate of projects in development. During the summit, Shimamura attended private pitching sessions and, after individual meeting
Takeda’s Zasocitinib Demonstrates Consistent, High Rates of Skin Clearance Across the Body, Including Hard-to-Treat and High-Impact Sites, in Phase 3 Psoriasis Studies17.7.2026 00:00:00 CEST | Press release
On average, about 75% of patients with scalp psoriasis treated with zasocitinib achieved clear or almost clear skin at week 16 Approximately 70% of patients with palmoplantar disease treated with zasocitinib achieved clear or almost clear skin at week 16 Zasocitinib demonstrated statistically significant improvements in Nail Psoriasis Severity Index (NAPSI) versus placebo Results reinforce the potential of zasocitinib to deliver rapid and durable skin clearance, including in the hardest-to-treat areas, in a convenient once-daily pill Takeda (TSE:4502/NYSE:TAK) announced new data from the two pivotal Phase 3 studies of zasocitinib (TAK-279), a next-generation, highly selective and potent oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented at the 2026 American Academy of Dermatology (AAD) Innovation Academy, these secondary endpoint data show that zasocitinib demonstrated consistent and high rates of skin clearance across hard-to-
Merz Completes Inaugural €450 Million Schuldschein Loan Issuance16.7.2026 23:36:00 CEST | Press release
Debut transaction more than three times oversubscribed The Merz Group has successfully completed its first-ever Schuldschein loan issuance, placing a total volume of €450 million in the debt capital market – a multiple of three relating to the launch volume. The debut transaction was significantly oversubscribed and attracted strong interest from all investor groups. The proceeds were settled and paid out today. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260716926041/en/ Dr. Almuth Steinkühler, Chief Financial Officer Merz Group The transaction comprises both fixed- and floating-rate tranches with maturities of three, five, seven, and ten years. Around 50 German and international investors participated, representing a broad range of institutions, including private banks, German federal state-owned banks, public savings banks, cooperative banks, pension funds and occupational pension institutions. With the successful plac
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom